Expanded Access to ABBV-706

Sponsor
AbbVie
Study ID
NCT07310277
Status
Available

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • ABBV-706 — DRUG
    Intravenous (IV) Infusion

Study Details

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-706 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Key Dates

Status verified
Dec 2025

Central Contacts

Related Studies